Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
PanGenomic Health, Inc. Class A ( (TSE:NARA) ) has issued an update.
PanGenomic Health Inc. will present its Agenta Health e-Commerce platform at the Vivacity Wellness Conference in Vancouver, showcasing its holistic health and wellness products. Additionally, the company successfully raised $975,000 through the exercise of 7,500,000 share purchase warrants, which will be used for general corporate and working capital purposes.
Spark’s Take on TSE:NARA Stock
According to Spark, TipRanks’ AI Analyst, TSE:NARA is a Underperform.
The overall stock score is driven by severe financial instability, with no revenue generation and increasing net losses. Technical analysis provides a mixed picture, suggesting potential short-term recovery but still reflecting overall negative momentum. The negative P/E ratio and lack of dividend yield further decrease the stock’s attractiveness.
To see Spark’s full report on TSE:NARA stock, click here.
More about PanGenomic Health, Inc. Class A
PanGenomic Health is a precision health company specializing in a self-care digital platform that provides personalized, evidence-based information about natural treatments. As a British Columbia benefit company, its mission is to offer alternative health solutions tailored to individual health profiles.
Average Trading Volume: 41,203
Technical Sentiment Signal: Buy
Current Market Cap: C$28.09M
See more insights into NARA stock on TipRanks’ Stock Analysis page.